Drug interactions
Buprenorphine long-acting + Scopolamine
Severity: Major
Buprenorphine long-acting and Scopolamine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Long-acting injectable buprenorphine gives prolonged opioid exposure that cannot be quickly withdrawn. Scopolamine adds sedative effects, raising the risk of excessive drowsiness, cognitive impairment and respiratory depression.
What this interaction means in plain words
Buprenorphine long-acting and Scopolamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive CNS depression from opioid partial agonism and central antimuscarinic activity.
What to do
Avoid scopolamine where an alternative exists, and otherwise use the lowest dose for the shortest time. Monitor for sedation and respiratory depression, remembering that buprenorphine effects persist after the last injection.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine long-acting and Scopolamine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Scopolamine
Frequently asked questions
Can I take Buprenorphine long-acting with Scopolamine?
MediHelp rates the interaction as major. Buprenorphine long-acting and Scopolamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Long-acting injectable buprenorphine gives prolonged opioid exposure that cannot be quickly withdrawn. Scopolamine adds sedative effects, raising the risk of excessive drowsiness, cognitive impairment and respiratory depression.
How serious is the interaction between Buprenorphine long-acting and Scopolamine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid scopolamine where an alternative exists, and otherwise use the lowest dose for the shortest time. Monitor for sedation and respiratory depression, remembering that buprenorphine effects persist after the last injection.
What other medicines interact with Scopolamine?
MediHelp also lists interactions of Scopolamine with, for example, Benzhydrocodone / acetaminophen, Buprenorphine subdermal implant, Buprenorphine transdermal. The full list is on the Scopolamine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
